ICD-10-PCS 2027 procedure code
XW043B3Introduction of Cytarabine and Daunorubicin Liposome Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 3
Short description: Introduce cytarab/daunorub in Central Vein, Perc, New Tech 3
Code last changed in FY2018 (effective October 1, 2017). Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data
About XW043B3
XW043B3 is the ICD-10-PCS code for a introduction procedure on the central vein using a percutaneous approach with cytarabine and daunorubicin liposome antineoplastic (qualifier: new technology group 3). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.
In plain terms, this corresponds to injection or infusion of cancer chemotherapeutic substance, the ICD-9-CM procedure title it maps to (99.25).
For a different body part, codes include XW033B3 (peripheral vein).
With a different device, use XW043F3 (other new technology therapeutic substance).
It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.
It was added in FY2018, effective October 1, 2017.
What each character means
- 1. Section
- XNew Technology
- 2. Body System
- WAnatomical Regions
- 3. Operation
- 0Introduction
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
- 4. Body Part
- 4Central Vein
- 5. Approach
- 3Percutaneous
Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure
- 6. Device / Substance / Technology
- BCytarabine and Daunorubicin Liposome Antineoplastic
Includes: VYXEOS(tm)
- 7. Qualifier
- 3New Technology Group 3
Other versions of this procedure
Different body part
Different device / substance / technology
Different qualifier
ICD-9-CM equivalent
Converter →- 99.25Injection or infusion of cancer chemotherapeutic substanceapproximate
From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2018 (effective 10/1/2017): Added
- No changes since FY2018.
Common questions about XW043B3
Is XW043B3 a valid ICD-10-PCS code for 2027?
- Yes. XW043B3 is valid for inpatient procedures from October 1, 2026 through September 30, 2027.
What is the ICD-9 procedure code for XW043B3?
- The CMS GEMs map XW043B3 to ICD-9-CM 99.25 (Injection or infusion of cancer chemotherapeutic substance).